Serenity, the small-cap stock-picker who builds his portfolio by back-mapping the AI supply chain, turned his attention today to robotics rather than his usual photonics chokepoints, reacting to a landmark event in the humanoid space.

A new public benchmark for humanoids. Chinese robotics firm Unitree (listed in Shanghai under 688836) made its market debut, and Serenity noted the scale of the reception: shares surged nearly 492% to value the company around $53.3 billion. He framed this as the moment public markets finally got a genuine pure-play humanoid benchmark — a listed company whose entire value rests on humanoid and quadruped robots, rather than being buried inside a larger conglomerate. His read is that investor appetite for dedicated humanoid names is materially larger than most expected.

That distinction matters to how Serenity thinks about the sector. He treats Tesla (TSLA) — a trillion-dollar-plus company whose Optimus humanoid program he considers the engine of his broader robotics supply-chain thesis — as a case where the robot story is diluted inside a much bigger business. He admires the execution but prefers to play the theme through under-the-radar component suppliers rather than owning the carmaker itself. Unitree, by contrast, offers a cleaner public read on how the market prices humanoids on their own.

Watching the next listings. Serenity also pointed ahead to Agility Robotics, the US humanoid maker backed by NVIDIA (NVDA) and Amazon (AMZN), which is expected to reach public markets via CCXI at a roughly $2.5 billion pre-money valuation in the fourth quarter. The gulf between that figure and Unitree's debut valuation underscores his point about pent-up demand for the category. NVIDIA sits at the center of his framework as the AI buildout's demand signal, while Amazon features as a hyperscaler whose enormous capex and robotics push feed the upstream bottlenecks he actually buys; here both appear as strategic backers validating the humanoid opportunity. CCXI is the vehicle through which Agility is slated to list.

No new positions or trades were disclosed today. The note read as thesis reinforcement: a real-world data point that the humanoid demand he has long anticipated is showing up in public-market valuations, strengthening the case for the supplier-level plays he favors over the marquee robot makers themselves.